4.8 Article

iGLuc: a luciferase-based inflammasome and protease activity reporter

期刊

NATURE METHODS
卷 10, 期 2, 页码 147-154

出版社

NATURE PUBLISHING GROUP
DOI: 10.1038/NMETH.2327

关键词

-

资金

  1. German Research Foundation [SFB704]
  2. European Research Council [ERC-2009-StG 243046]

向作者/读者索取更多资源

Measurement of protease activity in living cells or organisms remains a challenging task. We here present a transgene-encoded biosensor that reports the proteolytic activity of caspase-1 in the course of inflammasome activation and that of other proteases in a highly sensitive and specific manner. This protease reporter is based on the biological activity of a pro-interleukin (IL)-1 beta-Gaussia luciferase (iGLuc) fusion construct, in which pro-IL-1 beta-dependent formation of protein aggregates renders GLuc enzyme inactive. Cleavage leads to monomerization of this biosensor protein, resulting in a strong gain in luciferase activity. Exchange of the canonical caspase-1 cleavage site in this reporter construct allows the generation of protease biosensors with additional specificities. The high sensitivity, signal-to-background ratio and specificity of the iGLuc system renders it a useful tool to study proteolytic events in mouse and human cells at high throughput and to monitor protease activity in mice in vivo.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.8
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

Review Biochemistry & Molecular Biology

Regulation of ubiquitin and ubiquitin-like modifiers by phosphorylation

Nathaniel L. Hepowit, Carl-Christian Kolbe, Sarah R. Zelle, Eicke Latz, Jason A. MacGurn

Summary: The regulatory influence of ubiquitin in cellular processes is vast, with phosphorylation playing a key role in enhancing the complexity of the ubiquitin code. Phosphorylation can affect the function of ubiquitin at different sites and its crosstalk with other modifiers.

FEBS JOURNAL (2022)

Article Neurosciences

Soluble TAM receptors sAXL and sTyro3 predict structural and functional protection in Alzheimer's disease

Frederic Brosseron, Anne Maass, Luca Kleineidam, Kishore Aravind Ravichandran, Pablo Garcia Gonzalez, Roisin M. McManus, Christina Ising, Francesco Santarelli, Carl-Christian Kolbe, Lisa M. Haesler, Steffen Wolfsgruber, Marta Marquie, Merce Boada, Adelina Orellana, Itziar de Rojas, Sandra Roeske, Oliver Peters, Nicoleta-Carmen Cosma, Arda Cetindag, Xiao Wang, Josef Priller, Eike J. Spruth, Slawek Altenstein, Anja Schneider, Klaus Fliessbach, Jens Wiltfang, Bjorn H. Schott, Katharina Buerger, Daniel Janowitz, Martin Dichgans, Robert Perneczky, Boris-Stephan Rauchmann, Stefan Teipel, Ingo Kilimann, Doreen Goerss, Christoph Laske, Matthias H. Munk, Emrah Duzel, Renat Yakupov, Laura Dobisch, Coraline D. Metzger, Wenzel Glanz, Michael Ewers, Peter Dechent, John Dylan Haynes, Klaus Scheffler, Nina Roy, Ayda Rostamzadeh, Charlotte E. Teunissen, Natalie L. Marchant, Annika Spottke, Mathias Jucker, Eicke Latz, Michael Wagner, David Mengel, Matthis Synofzik, Frank Jessen, Alfredo Ramirez, Agustin Ruiz, Michael T. Heneka

Summary: Understanding neuroinflammation in Alzheimer's disease is crucial, as evident from the analysis of inflammatory biomarkers in pre-dementia individuals showing close interactions between inflammation and accumulating neurodegeneration. Additionally, higher levels of specific biomarkers are associated with larger brain structure and stable cognitive outcomes at follow-up.

NEURON (2022)

Review Rheumatology

Intracellular Sensing of DNA in Autoinflammation and Autoimmunity

Susan MacLauchlan, Katherine A. Fitzgerald, Ellen M. Gravallese

Summary: Evidence has shown that DNA plays a unique role in distinguishing between endogenous and foreign DNA, posing a challenge in disease discrimination. Autoinflammatory diseases resulting from gene mutations or DNA sensing pathway activation provide insight into the role of DNA in inflammation. This review discusses the current understanding of intracellular DNA sensing and its relevance to various diseases, as well as the development of therapies targeting these pathways.

ARTHRITIS & RHEUMATOLOGY (2022)

Review Immunology

Innate sensing of mRNA vaccines

Christine Wuebben, Eva Bartok, Gunther Hartmann

Summary: The success of RNA applications, such as mRNA vaccines and RNA therapeutics, holds great promise for future drug development. Understanding innate RNA sensing can lead to further improvements in mRNA vaccines and RNA therapeutics.

CURRENT OPINION IN IMMUNOLOGY (2022)

Correction Immunology

Monocyte-derived macrophages aggravate pulmonary vasculitis via cGAS/STING/IFN-mediated nucleic acid sensing (vol 219, e0220759, 2022)

Nina Kessler, Susanne F. Viehmann, Calvin Krollmann, Karola Mai, Katharina M. Kirschner, Hella Luksch, Prasanti Kotagiri, Alexander M. C. Boehner, Dennis Huugen, Carina C. de Oliveira Mann, Simon Otten, Stefanie A. I. Weiss, Thomas Zillinger, Kristiyana Dobrikova, Dieter E. Jenne, Rayk Behrendt, Andrea Ablasser, Eva Bartok, Gunther Hartmann, Karl-Peter Hopfner, Paul A. Lyons, Peter Boor, Angela Roesen-Wolff, Lino L. Teichmann, Peter Heeringa, Christian Kurts, Natalio Garbi

JOURNAL OF EXPERIMENTAL MEDICINE (2022)

Review Cell Biology

Long non-coding RNAs: definitions, functions, challenges and recommendations

John S. S. Mattick, Paulo P. P. Amaral, Piero Carninci, Susan Carpenter, Howard Y. Y. Chang, Ling-Ling Chen, Runsheng Chen, Caroline Dean, Marcel E. E. Dinger, Katherine A. A. Fitzgerald, Thomas R. R. Gingeras, Mitchell Guttman, Tetsuro Hirose, Maite Huarte, Rory Johnson, Chandrasekhar Kanduri, Philipp Kapranov, Jeanne B. B. Lawrence, Jeannie T. T. Lee, Joshua T. T. Mendell, Timothy R. R. Mercer, Kathryn J. J. Moore, Shinichi Nakagawa, John L. L. Rinn, David L. L. Spector, Igor Ulitsky, Yue Wan, Jeremy E. E. Wilusz, Mian Wu

Summary: Genes encoding lncRNAs are abundant in complex organisms and are transcribed by RNA polymerase I, II, and III, as well as processed introns. The classification and annotation of lncRNAs are challenging due to their various functions, isoforms, and interactions with other genes. These lncRNAs evolve rapidly, are cell type-specific, and regulate multiple cellular processes, including gene expression and translation control.

NATURE REVIEWS MOLECULAR CELL BIOLOGY (2023)

Editorial Material Immunology

TBK1 inhibition unleashes RIPK1, resensitizing tumors to immunotherapy

Michelle A. Kelliher, Katherine A. Fitzgerald

Summary: Resistance mechanisms have hindered the effectiveness of immune checkpoint blockade therapies, but inhibition of TBK1 can restore their efficacy by sensitizing tumors to RIPK1 kinase-dependent cell death.

TRENDS IN IMMUNOLOGY (2023)

Article Cell Biology

RIG-I immunotherapy overcomes radioresistance in p53-positive malignant melanoma

Silke Lambing, Yu Pan Tan, Paraskevi Vasileiadou, Stefan Holdenrieder, Patrick Mueller, Christian Hagen, Stephan Garbe, Rayk Behrendt, Martin Schlee, Jasper G. van den Boorn, Eva Bartok, Marcel Renn, Gunther Hartmann

Summary: Radiotherapy induces DNA damage and activates cell death pathways, but its effectiveness is limited in radioresistant tumors such as melanoma. This study shows that activation of the immune sensing receptor RIG-I can enhance irradiation-induced tumor cell death, leading to improved survival in melanoma models. The results suggest that combining RIG-I ligands with radiotherapy may be a promising approach for treating radioresistant tumors with functional p53 pathways, such as melanoma.

JOURNAL OF MOLECULAR CELL BIOLOGY (2023)

Article Biochemistry & Molecular Biology

Transcriptional licensing is required for Pyrin inflammasome activation in human macrophages and bypassed by mutations causing familial Mediterranean fever

Matthew S. J. Mangan, Friederike Gorki, Karoline Krause, Alexander Heinz, Anne Pankow, Thomas Ebert, Dieter Jahn, Karsten Hiller, Veit Hornung, Marcus Maurer, Florian Schmidt, Ralf Gerhard, Eicke Latz

Summary: This study reveals that human monocyte-derived macrophages (hMDM) have a different regulation of Pyrin activation compared to monocytes and murine macrophages. Unlike the latter, hMDM fail to activate Pyrin in response to known Pyrin activators and require prolonged priming and increased Pyrin expression for Pyrin inflammasome response. However, FMF mutations lift the requirement for prolonged priming, enabling Pyrin activation without additional inflammatory signals. Additionally, the study unexpectedly finds that TcdB can activate the NLRP3 inflammasome in hMDM even without a Pyrin response.

PLOS BIOLOGY (2022)

Article Cell Biology

Loss of the Immunomodulatory Transcription Factor BATF2 in Humans Is Associated with a Neurological Phenotype

Gabor Zsurka, Maximilian L. T. Appel, Maximilian Nastaly, Kerstin Hallmann, Niels Hansen, Daniel Nass, Tobias Baumgartner, Rainer Surges, Gunther Hartmann, Eva Bartok, Wolfram S. Kunz

Summary: This study reports on a family with three affected individuals exhibiting symptoms resembling a neurodevelopmental disorder. Whole-exome sequencing identified a homozygous stop-gain mutation in the BATF2 gene, which is predominantly expressed in macrophages and monocytes and plays a role in modulating pro-inflammatory responses. Transcriptome analysis showed altered expression of interferon-stimulated genes and elevated responses to innate immune stimuli in the patients' blood. These findings suggest that BATF2 may be a novel disease-associated gene candidate for severe epilepsy and mental retardation related to dysregulation of immune responses, highlighting the importance of neuroinflammation in epilepsy.
Editorial Material Cell Biology

ERADication of STING limits inflammation

Kevin MingJie Gao, Katherine A. Fitzgerald

Summary: Endoplasmic-reticulum-associated degradation of the adaptor STING by SEL1L-HRD1 regulates steady-state STING levels to limit STING-driven inflammation, according to the study by Jie et al.

NATURE CELL BIOLOGY (2023)

Article Rheumatology

A path towards personalized medicine for autoinflammatory and related diseases

Jonathan J. J. Miner, Katherine A. A. Fitzgerald

Summary: Next-generation sequencing has revolutionized the field of genetics and has allowed for the discovery of rare autoinflammatory diseases and their corresponding mutations. This has opened up opportunities for personalized medicine and has shed light on more common forms of autoimmunity and autoinflammation. The rapid and cost-effective sequencing of individual genomes is changing the practice of rheumatology.

NATURE REVIEWS RHEUMATOLOGY (2023)

Article Biochemistry & Molecular Biology

Influenza A Infection Stimulates RIG-I and Enhances Effector Function of Primary Human NK Cells

Adham Abuelola Mohamed, Sofia Soler, Julia Wegner, Eva Bartok, Sanda Stankovic, Andrew G. G. Brooks, Martin Schlee

Summary: NK cell activation in response to Influenza A virus infection depends on the cytosolic RNA receptor RIG-I, and activation of RIG-I enhances both the antiviral defense and cytotoxic effector function of NK cells against target cells.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2023)

Article Respiratory System

Tetracycline ameliorates silica-induced pulmonary inflammation and fibrosis via inhibition of caspase-1

Konrad Peukert, Folkert Steinhagen, Mario Fox, Caroline Feuerborn, Susanne Schulz, Benjamin Seeliger, Patrick Schuss, Matthias Schneider, Stilla Frede, Andrea Sauer, Christian Putensen, Eicke Latz, Christoph Wilhelm, Christian Bode

Summary: The study found that tetracycline can reduce silica-induced lung injury and fibrosis associated with chronic silicosis by inhibiting caspase-1 activation and the production of IL-1 beta. Tetracycline may be an effective treatment for patients with silicosis and other diseases involving silicotic inflammation.

RESPIRATORY RESEARCH (2022)

Review Medicine, General & Internal

New Aspects of Kidney Fibrosis-From Mechanisms of Injury to Modulation of Disease

Marcus J. Moeller, Rafael Kramann, Twan Lammers, Bernd Hoppe, Eicke Latz, Isis Ludwig-Portugall, Peter Boor, Juergen Floege, Christian Kurts, Ralf Weiskirchen, Tammo Ostendorf

Summary: Organ fibrogenesis, characterized by a common pathophysiological final pathway, independent of the progressive disease, offers potential therapeutic targets. The SFB/TRR57 consortium successfully identified new mechanisms and established novel therapeutic approaches to interfere with hepatic and renal fibrosis. This review focuses on the consortium's key findings related to renal fibrosis, addressing new relevant mechanisms, immunological contributors, and modulation strategies.

FRONTIERS IN MEDICINE (2022)

暂无数据